A Study of Obexelimab in Patients With Warm Autoimmune Hemolytic Anemia (SApHiAre)
Clinical trial NCT05786573 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05786573
- Sponsor
- Zenas BioPharma (USA), LLC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-25
- Primary completion
- 2026-06-30
- Enrollment
- 134
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.